Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:01 PM
Ignite Modification Date:
2025-12-24 @ 12:01 PM
NCT ID:
NCT04730661
Eligibility Criteria:
Inclusion Criteria:
* Adult (≥18 years old)
* Admit to emergency department for suspected SARS-Cov2 infection
* SARS-CoV2 infection confirmed by Real Time Polymerase Chain Reaction (RT - PCR) before the first discharge of emergency department
* Patient affiliated or beneficiary of a health care insurance
* Effective contraception in women of childbearing age. For postmenopausal women, amenorrhea for at least 12 months before the inclusion visit
Exclusion Criteria:
* Patient presenting criteria for admission to intensive care: signs of acute respiratory distress , respiratory rate\> 30 / min, oxygen dependence \> 6L / min on face mask for an SpO2 ≥ 95% or an arterial oxygen pressure \>8kPa, neurological disorders, systolic blood pressure (SBP) \<90mmHg despite fluid resuscitation, lactates\> 2mmol / L, bradycardia, or heart rate disorders
* Patient with SpO2 \<90% in spontaneous ventilation in room air at rest
* Patient with functional impairment or deterioration of the general condition leading to the inability to perform STST
* Patient with a resting SBP\> 180 mmHg or resting diastolic blood pressure (DBP)\> 100 mmHg or resting heart rate (HR)\> 120 / min
* Patient with decompensated or unbalanced cardiac pathology
* Patient previously included in the study following a previous admission to emergency department
* Patient deprived of liberty, unable to consent freely
* Patient non affiliated or beneficiary of a health care insurance
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04730661
Study Brief:
Protocol Section:
NCT04730661